ENT and Head and Neck Surgery Department, CHU UCL Namur- Site Godinne, Avenue du Docteur Gaston Therasse 1, 5530, Namur, Yvoir, Belgium.
Centre de Technologies Moléculaires Appliquées, Institut de Recherche Experimentale et Clinique, UCL, Brussels, Belgium.
Eur Arch Otorhinolaryngol. 2020 Oct;277(10):2883-2892. doi: 10.1007/s00405-020-05984-y. Epub 2020 May 4.
With the development of minimal invasive procedure, trans-oral robotic surgery (TORS) is expanding in the field of ENT. Most reviews focus on oropharyngeal and laryngeal (supra-glottic) localization. We report here the feasibility and outcomes of TORS hypopharyngectomy (TORSH) for selected patients with hypopharyngeal tumor.
Between September 2009 and July 2017, 22 patients, retrospectively included, underwent TORSH with curative intent.
From 22 successful hypopharyngectomy, no conversion to open procedure was needed. Three patients (13%) presented a post-operative bleeding and were managed by surgical revision. No fistula was encountered. The 3-year overall survival and disease-specific survival rates were 54 and 92%, respectively. Patients started oral feeding after an average of 7 days. Naso-gastric feeding tubes were removed after a median period of 16 days. Two patients (9%) needed a transient gastrostomy (< 1 year). Three patients (13%) received a transient tracheostomy (< 2 months). Median hospitalization stay was 13 days.
TORSH is a safe technique. Patients' outcomes are favorable and the post-operative morbidity is reduced compared to open neck approach. Hospitalization length and safe swallowing time are reduced.
随着微创技术的发展,经口机器人手术(TORS)在耳鼻喉科领域不断扩展。大多数综述都集中在口咽和声门(声门上)定位。我们在此报告了 TORS 下咽切除术(TORSH)治疗选定下咽肿瘤患者的可行性和结果。
2009 年 9 月至 2017 年 7 月,回顾性纳入 22 例接受 TORSH 治疗的患者。
22 例成功的下咽切除术无一例转为开放性手术。3 例(13%)患者术后出现出血,行手术修正治疗。无吻合口瘘发生。3 年总生存率和疾病特异性生存率分别为 54%和 92%。患者平均在 7 天后开始经口进食,中位时间为 16 天后拔除鼻饲管。2 例(9%)患者需要暂时行胃造口术(<1 年)。3 例(13%)患者需要暂时性气管造口术(<2 个月)。中位住院时间为 13 天。
TORSH 是一种安全的技术。与开放颈部入路相比,患者的治疗效果良好,术后发病率降低。住院时间和安全吞咽时间缩短。